If the $5m goes towards 100% to the ANZ cancer trials as you said assuming it's true, then its shareholders who are funding the trials and not them as per ASX announcements. Therefore, IVX should retain the IP & Patents and not the CHO Group.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.015(12.0%) |
Mkt cap ! $9.320M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 10.5¢ | $24.18K | 211.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 28316 | 1 |
View Market Depth
| Last trade - 15.59pm 25/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |